Dr. Roberts has been treating his patients for over a year.
How Kyle Hodgetts developed CAVADEX over 5 years of research.
Our Research

Treatment for Atherosclerosis
CAVADEXTRIN® is a brand of Cyclodextrin developed by Cholrem that removes cholesterol and plaque from arteries.
Research into cyclodextrin is quickly proving cyclodextrin will emerge as one of the major therapeutical treatments of the 21st century. Scientific studies and research into cyclodextrin are showing that enhanced cholesterol transport within the body has major benefits for treating age-related conditions.
CHOLREM is the world leader in this research

The CAVADEXTRIN® molecule
Developed by Cholrem in 2019, the CAVADEXTRIN® molecule absorbs cholesterol from arterial plaque and transports it safely out through the urinary system.
CAVADEXTRIN® has shown to lower triglycerides by 50% and cholesterol by 40% in just 2 weeks.
CAVADEXTRIN® removes the cholesterol from your arteries.
Learn more about CAVADEXTRIN